How will I know if my Kidney Cancer treatment is working
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
How to Know If Your Kidney Cancer Treatment Is Working
This is one of the most important questions you can ask your care team. Let me walk you through the main ways doctors monitor kidney cancer treatment response, and what you should be tracking.
Standard Monitoring Methods
1. Imaging Scans (The Primary Tool)
Your oncologist will use CT scans, MRI, or PET scans at regular intervals (typically every 8-12 weeks, depending on your treatment) to:
- Measure tumor size - comparing current scans to baseline (your starting point)
- Check for new tumors - looking for spread to other organs
- Assess existing metastases - if cancer has spread, monitoring those sites
Important context: As noted in the CancerPatientLab webinars on response monitoring, imaging has limitations. A CT scan can typically detect tumors about 1 cubic centimeter in size (roughly a billion cancer cells). Doctors are working to detect changes earlier, but the key question isn't just "Can we see it?" but "Will detecting it earlier actually improve my outcome?"
2. Blood Tests
Your doctor may order:
- Complete blood count (CBC) - checking for anemia or other blood cell changes
- Metabolic panel - kidney function, liver function
- Tumor markers - though kidney cancer doesn't have a single reliable marker like PSA in prostate cancer
3. Physical Symptoms & Quality of Life
Pay attention to:
- Energy levels and fatigue
- Pain or discomfort
- Appetite and weight changes
- Ability to do daily activities
- Side effects from treatment (which may decrease if the drug is working and your body adjusts)
Understanding Treatment Response Categories
Doctors classify responses using standardized criteria (RECIST 2.0 is the current standard):
| Response Type | What It Means | |---|---| | Complete Response | No radiologic evidence of tumor (cancer vanishes on imaging) | | Partial Response | Tumor shrinks by at least 30% in diameter | | Stable Disease | Tumor doesn't grow, but doesn't shrink significantly | | Progressive Disease | Tumor grows or new tumors appear |
Important note: According to CancerPatientLab webinars on treatment assessment, stable disease (where your cancer stops growing) is increasingly recognized as valuable. As one expert noted, if you can "get your disease to stop spreading," that's a meaningful benefit—you might live many more years without progression.
Emerging Monitoring Tools for Kidney Cancer
Beyond standard imaging, newer approaches are becoming available:
Liquid Biopsies (Blood Tests)
These tests look for circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) in your blood. According to the CancerPatientLab webinars on liquid biopsies, these can potentially:
- Detect recurrence earlier than imaging
- Monitor treatment response in real-time
- Provide information about whether your treatment is working before imaging shows changes
However: The webinars emphasize an important principle—just because we can detect something earlier doesn't automatically mean it improves outcomes. Your doctor needs to know: "Will detecting this earlier actually help me?"
Functional Testing (Emerging)
Some specialized labs can test your tumor cells against different drugs to predict which treatments will work best for your specific cancer. This is still evolving but may help guide treatment decisions if you need to switch therapies.
Key Questions to Ask Your Oncologist
-
"What is my baseline?" - Get clear numbers from your initial scans (tumor size, location, number of lesions)
-
"How often will we scan, and what are we looking for?" - Understand your monitoring schedule
-
"What counts as a good response for my specific situation?" - Response goals vary based on stage and type of kidney cancer
-
"If my tumor shrinks but I have bad side effects, what are our options?" - Sometimes dose adjustments or treatment changes are possible
-
"Are there blood tests or other monitoring tools that might help us track response between scans?" - Ask about liquid biopsies or other emerging tests
-
"What will we do if the treatment isn't working?" - Understand your backup plan and timeline for reassessment
-
"How will we know when to switch treatments?" - What specific findings would trigger a change in your therapy?
What to Track Yourself
Keep a simple log of:
- Scan dates and results (get copies for your records)
- How you feel - energy, pain, side effects
- Any new symptoms - report these promptly
- Questions that come up - write them down for your next appointment
According to the CancerPatientLab webinars on patient data ownership, you have the right to access all your [ID removed] and imaging results. Don't hesitate to request copies—having your own records helps you stay informed and can be valuable if you seek second opinions.
The Bottom Line
Treatment response is measured through a combination of:
- Imaging (the gold standard)
- Blood work (supporting information)
- How you feel (quality of life matters)
- Emerging tests (liquid biopsies and functional assays are becoming more available)
The most important thing is regular communication with your care team. If you're not clear on how your treatment is being monitored or what the results mean, ask. Your oncologist should be able to explain your specific response in terms you understand.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your treatment monitoring.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Kidney Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Kidney Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: